Login to Your Account

Pharma: Clinic Roundup

Wednesday, February 8, 2012
• Eli Lilly and Co., of Indianapolis, reported data from a Phase III study showing that both Cialis (tadalafil) and tamsulosin significantly improved scores on the International Prostate Symptom Score, compared to placebo, in men with signs and symptoms suggestive of benign prostatic hyperplasia (BPH). Cialis improved erectile dysfunction (ED) in those men who had both signs and symptoms of BPH and ED. Data were published in European Urology.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription